During the past decade, Memorial Healthcare conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Memorial Healthcare" #1 sponsor was "Sanofi" with 3 trials, followed by "EMD Serono Research & Development Institute, Inc." with 2 trials sponsored, "NSABP Foundation Inc" with 2 trials sponsored, "Biogen" with 1 trials sponsored and "Vertos Medical, Inc." with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Memorial Healthcare" #1 collaborator was "Merck KGaA, Darmstadt, Germany" with 2 trials as a collaborator, "AstraZeneca" with 1 trials as a collaborator, "Eli Lilly and Company" with 1 trials as a collaborator, "Genentech, Inc." with 1 trials as a collaborator and "National Cancer Institute (NCI)" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Memorial Healthcare" are "Breast Cancer" (2 trials), "Multiple Sclerosis" (2 trials), "Lumbar Spinal Stenosis" (1 trials), "Primary Progressive Multiple Sclerosis" (1 trials) and "Relapsing Forms of MS" (1 trials). Many other conditions were trialed in "Memorial Healthcare" in a lesser frequency.

Most popular intervention types in "Memorial Healthcare" are "Drug" (8 trials), "Device" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Tolebrutinib" (3 trials), "Cladribine Tablets" (2 trials), "Placebo to match Tolebrutinib" (2 trials), "Diroximel Fumarate" (1 trials) and "MILD" (1 trials). Other intervention names were less common.

The vast majority of trials in "Memorial Healthcare" are 8 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Memorial Healthcare". undefined are not yet recruiting, 3 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Memorial Healthcare, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Memorial Healthcare, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".

Memorial Healthcare has several departments that took part in Clinical trials: "McLaren Cancer Institute-Owosso" - 14 trials, "Memorial Healthcare Institute for Neurosciences and Multiple Sclerosis" - 4 trials